AT1 0.00% 2.8¢ atomo diagnostics limited

Joining the dots - Atomo announcement regarding its commercial...

  1. 84 Posts.
    lightbulb Created with Sketch. 9
    Joining the dots - Atomo announcement regarding its commercial arrangements with Access Bio Inc.

    From a recent news article on 12th Sept -
    "There is a big shortage in the market right now across the board," said Ron Gutman, co-CEO of Intrivo, a testing manufacturer. "We have a lot more demand than we’ve ever seen before."

    Intrivio is the technology and business partner of Access Bio, one of six companies with Food and Drug Administration authorization to sell home tests directly to consumers. . Intrivio/Access Bio expect to begin selling retail rapid tests in the coming weeks.
 
watchlist Created with Sketch. Add AT1 (ASX) to my watchlist
(20min delay)
Last
2.8¢
Change
0.000(0.00%)
Mkt cap ! $17.89M
Open High Low Value Volume
2.7¢ 2.8¢ 2.5¢ $3.866K 140.1K

Buyers (Bids)

No. Vol. Price($)
4 472951 2.5¢
 

Sellers (Offers)

Price($) Vol. No.
2.8¢ 143054 2
View Market Depth
Last trade - 16.10pm 12/07/2024 (20 minute delay) ?
AT1 (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.